Table 2.

Cases of patients with COVID-19 who developed IE.

Author	Age	Gender	Location	Microorganism	IE-related ICU care	IE-related cardiac surgery	In-hospital mortality
De Castro20	34	Female	United States	Haemophilus parainfluenzae		Yes
Amir21	61	Male	Indonesia	Negative (recent prior antibiotics)
Alizadeh22	50	Male	United Kingdom	MSSA	Yes
Alizadehasl23	24	Male	Iran	MSSA
Kumanayaka24	38	Male	United States	Streptococcus mitis/oralis
Regazzoni25	70	Male	Italy	MSSA
Lowell26	59	Female	United States	Streptococcus agalactiae		Yes
Kraiem27	60	Male	Tunisia	Enterococcus faecalis
Benmalek28	76	Female	Morocco	Coagulase-negative staphylococcus	Yes
Choudhury29	73	Male	United States	MSSA
Joshi30	28	Male	United States	Serratia marcescens	Yes		Yes
Hayes 31	38	Male	United States	Streptococcus mitis/oralis	Yes	Yes
Spinoni32	57	Male	Italy	MRSA
Dias33	36	N/A	Brazil	MRSA			Yes
De Vivo34	77	Male	Italy	Staphylococcus epidermidis		Yes
Velez-Paez35	53	Male	Ecuador	Staphylococcus hominis			Yes
Sanders 36	38	Male	United States	Enterococcus faecalis		Yes
Schizas37	59	Male	Greece	Staphylococcus lugdunensis	Yes	Yes
Ramos-Martinez38	68	Female	Spain	Enterococcus faecalis		Yes	Yes
Ramos-Martinez38	67	Male	Spain	MSSA	Yes		Yes
Brotherton39	31	Male	United States	MSSA

Abbreviations: IE, infective endocarditis; ICU, intensive care unit; N/A, not available; MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus